Health-care company stocks rose Wednesday as trade tensions were partially offset by stronger-than-expected services PMI numbers in the U.S.
Jazz Pharmaceuticals' $935 million deal to buy Chimerix could be the start of deal-making by the biopharma, Piper Sandler's David Amsellem and Alex von Riesemann said.
Moderna shares rose sharply after a German court in Duesseldorf ruled that Pfizer and partner BioNTech broke a coronavirus vaccine patent held by Moderna, Reuters reported.
Write to Paulo Trevisani at paulo.trevisani@wsj.com
(END) Dow Jones Newswires
March 05, 2025 17:17 ET (22:17 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.